Investor Presentaiton

Achievements to date-- 2023 May June July August EUR 12.5 million in financing from Highbridge/Whitebox EUR 10 million in cash from our sale of Mayne Pharma shares Positive preclinical data for CSF-1R tyrosine kinase inhibitors EUR 17.05 million Canadian binding term sheet for DONESTAⓇ with Searchlight Pharma EUR 20 million equity private placement with Armistice Capital (with up to EUR 45 million more possible) API Supply agreement for Estetrol (E4) native estrogen with Gedeon Richter EUR 1.25 million milestone payment from Fuji Pharma, ESTELLEⓇ Japan partner October EUR 1.5 million milestone payment from Searchlight for execution of Canadian agreement EUR 2.5 million milestone payment from Fuji Pharma, ESTELLEⓇ Japan partner Mithra Investor Presentation Novem O

View entire presentation